NVAX Financial Facts
General and administrative: 13.56MBasic and diluted net loss per share: -0.24
See Full Income Statement
Additional paid-in capital: 932.21M
Deferred revenue: 30.16M
See Full Balance Sheet
Novavax, Inc. (NVAX) Earnings
|
Expand Research on NVAX
| Next EPS Date | 5/7/24 | EPS Growth Rate | +72.1% |
|---|---|---|---|
| Average EPS % Beat Rate | -43.3% | Revenue Growth Rate | +85.7% |
| Average % Move 1-Wk after EPS | -8.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/10  |
 |
Q310 | -$0.10 | -$0.09 | -$0.01 | N/A | N/A | N/A |  | | Details |
| 3/28/11 |
|
Q410 | -$0.06 | -$0.09 | +$0.03 | $51K | $110K | N/A | | | Details |
| 5/9/11 |
Q111 | -$0.07 | -$0.07 | $0.00 | $834K | $2.29M | N/A | | | Details | |
| 8/5/11 | Q211 | -$0.04 | N/A | N/A | $3M | $2.74M | N/A | | | Details | |
| 11/4/11 |
|
Q311 | -$0.03 | -$0.05 | +$0.02 | $5M | $5.37M | N/A | | | Details |
| 3/9/12 |
|
Q411 | $0.03 | -$0.04 | +$0.07 | $5.85M | $6.87M | N/A | | | Details |
| 5/4/12 |
|
Q112 | -$0.06 | -$0.04 | -$0.02 | $4.64M | $7.36M | N/A | | | Details |
| 8/3/12 |
|
Q212 | -$0.05 | -$0.05 | $0.00 | $7.1M | $6.68M | N/A | | | Details |
